M&A Deal Summary |
|
---|---|
Date | 2022-12-21 |
Target | IsoPlexis |
Sector | Life Science |
Buyer(s) | Bruker Cellular Analysis |
Deal Type | Add-on Acquisition |
Deal Value | 58M USD |
Advisor(s) | Evercore Group (Financial) Cravath, Swaine & Moore (Legal) |
SEARCH BY
Try For Free 7-Day Free Trial
Category | Company |
---|---|
Founded | 2011 |
Sector | Life Science |
Revenue | 79M USD (2022) |
Bruker Cellular Analysis is a functional cell biology company that provides single-cell biology research tools to deliver deep insights into cellular function and new perspectives on phenomes and genotype-to-phenotype linkages. It enables scientists to reveal the most complete insights into cell function and obtain a full view of the behavior of each cell. Bruker Cellular Analysis was incorporated in 2011 and is based in EmeryVille, California.
DEAL STATS | # |
---|---|
Overall | 1 of 1 |
Sector (Life Science) | 1 of 1 |
Type (Add-on Acquisition) | 1 of 1 |
State (Connecticut) | 1 of 1 |
Country (United States) | 1 of 1 |
Year (2022) | 1 of 1 |
Size (of disclosed) | 1 of 1 |